MAM
TEVA icon

Meeder Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Meeder Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed – – 1881
2022
Q3 		$0 Buy
+7
New +$62 ﹤0.01% 2368
2015
Q4 		– Sell
-8,404
Closed -$474K – 861
2015
Q3 		$474K Sell
8,404
-51
-0.6% -$3.31K 0.05% 391
2015
Q2 		$500K Sell
8,455
-59,789
-88% -$3.69M 0.05% 338
2015
Q1 		$4.25M Sell
68,244
-9,939
-13% -$578K 0.46% 49
2014
Q4 		$4.5M Sell
78,183
-15,260
-16% -$850K 0.57% 45
2014
Q3 		$5.02M Buy
+93,443
New +$4.95M 0.74% 45

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Meeder Asset Management's TEVA Position: Q4 2022 in Review

Meeder Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 7 shares.

Meeder Asset Management first reported a position in TEVA in Q3 2014 and held it in 6 quarters. The position peaked at $5.02M in Q3 2014. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Meeder Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 7 Teva Pharmaceuticals shares in Q4 2022.
  • Meeder Asset Management first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Meeder Asset Management's Teva Pharmaceuticals position peaked at $5.02M in Q3 2014.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.